Kyorin Pharmaceutical Co.,ltd. (4569) Press Release
KYORIN Entered into Joint Marketing Agreement in Japan for Allergic Conjunctivitis Treatment Alesion Eyelid Cream 0.5%
Earlier from Kyorin Pharmaceutical Co.,ltd
- KYORIN Pharmaceutical: Operating profit fell 71.6% year-over-year as sales declined and R&D costs rose
- Kyorin Pharmaceutical Co Ltd - Kyorin Enters Into License Agreement With Biodol For Novel Neuropathic Pain Treatment
- TABLE-Kyorin Pharmaceutical - 9-MTH group results
- KYORIN Pharmaceutical: Strong nine-month results, but full-year outlook projects lower sales and profits